EP0174726A1 — Pyridine derivatives and their production
Assigned to Takeda Pharmaceutical Co Ltd · Expires 1986-03-19 · 40y expired
What this patent protects
The compound of the formula wherein R 1 is hydrogen, methoxy or trifluoromethyl, R 2 and R 3 are independently hydrogen or methyl, R" is a C 2-5 fluorinated alkyl and n denotes 0 or 1, or a pharmacologically acceptable salt thereof is novel, and useful for prophylaxi…
USPTO Abstract
The compound of the formula wherein R 1 is hydrogen, methoxy or trifluoromethyl, R 2 and R 3 are independently hydrogen or methyl, R" is a C 2-5 fluorinated alkyl and n denotes 0 or 1, or a pharmacologically acceptable salt thereof is novel, and useful for prophylaxis and therapy of digestive ulcers (e.g. gastric ulcer, duodenal ulcer) and gastritis.
Drugs covered by this patent
- Prilosec (omeprazole) · AstraZeneca (originally Astra AB)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.